SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Gaciong Zbigniew)
 

Sökning: WFRF:(Gaciong Zbigniew) > Mouse CCL9 Chemokin...

Mouse CCL9 Chemokine Acts as Tumor Suppressor in a Murine Model of Colon Cancer

Lazarczyk, Marzena (författare)
Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Genom, PL-05552 Jastrzebiec, Poland.
Kurzejamska, Ewa (författare)
Karolinska Institutet,Uppsala universitet,Neuroonkologi och neurodegeneration
Mickael, Michel-Edwar (författare)
Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Genom, PL-05552 Jastrzebiec, Poland.
visa fler...
Poznanski, Piotr (författare)
Karolinska Institutet
Skiba, Dominik (författare)
Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Genom, PL-05552 Jastrzebiec, Poland.
Sacharczuk, Mariusz (författare)
Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Genom, PL-05552 Jastrzebiec, Poland.;Med Univ Warsaw, Ctr Preclin Res & Technol, Dept Pharmacodynam, PL-02091 Warsaw, Poland.
Gaciong, Zbigniew (författare)
Med Univ Warsaw, Dept Internal Med Hypertens & Vasc Dis, PL-02091 Warsaw, Poland.
Religa, Piotr (författare)
Karolinska Inst, Dept Med, S-17176 Stockholm, Sweden.
visa färre...
Polish Acad Sci, Inst Genet & Anim Biotechnol, Dept Expt Genom, PL-05552 Jastrzebiec, Poland Neuroonkologi och neurodegeneration (creator_code:org_t)
MDPI, 2023
2023
Engelska.
Ingår i: Current Issues in Molecular Biology. - : MDPI. - 1467-3037 .- 1467-3045. ; 45:4, s. 3446-3461
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Colorectal cancer is the third most frequently diagnosed cancer in the world. Despite extensive studies and apparent progress in modern strategies for disease control, the treatment options are still not sufficient and effective, mostly due to frequently encountered resistance to immunotherapy of colon cancer patients in common clinical practice. In our study, we aimed to uncover the CCL9 chemokine action employing the murine model of colon cancer to seek new, potential molecular targets that could be promising in the development of colon cancer therapy. Mouse CT26.CL25 colon cancer cell line was used for introducing lentivirus-mediated CCL9 overexpression. The blank control cell line contained an empty vector, while the cell line marked as CCL9+ carried the CCL9-overexpressing vector. Next, cancer cells with empty vector (control) or CCL9-overexpressing cells were injected subcutaneously, and the growing tumors were measured within 2 weeks. Surprisingly, CCL9 contributed to a decline in tumor growth in vivo but had no effect on CT26.CL25 cell proliferation or migration in vitro. Microarray analysis of the collected tumor tissues revealed upregulation of the immune system-related genes in the CCL9 group. Obtained results suggest that CCL9 reveals its anti-proliferative functions by interplay with host immune cells and mediators that were absent in the isolated, in vitro system. Under specific study conditions, we determined unknown features of the murine CCL9 that have so far bee reported to be predominantly pro-oncogenic.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)

Nyckelord

CCL9
chemokine
CCR1
colon cancer

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy